These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9681820)

  • 21. Overexpression of cyclin D1 and cortactin is primarily independent of gene amplification in salivary gland adenoid cystic carcinoma.
    Greer RO; Said S; Shroyer KR; Marileila VG; Weed SA
    Oral Oncol; 2007 Sep; 43(8):735-41. PubMed ID: 17113340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of the EMS1 gene and its product, human Cortactin.
    Schuuring E; van Damme H; Schuuring-Scholtes E; Verhoeven E; Michalides R; Geelen E; de Boer C; Brok H; van Buuren V; Kluin P
    Cell Adhes Commun; 1998; 6(2-3):185-209. PubMed ID: 9823470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone.
    Liu S; Goldstein RH; Scepansky EM; Rosenblatt M
    Cancer Res; 2009 Nov; 69(22):8742-51. PubMed ID: 19887617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential role of HOXD9 in synoviocyte proliferation.
    Khoa ND; Nakazawa M; Hasunuma T; Nakajima T; Nakamura H; Kobata T; Nishioka K
    Arthritis Rheum; 2001 May; 44(5):1013-21. PubMed ID: 11352232
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The redistribution of cortactin into cell-matrix contact sites in human carcinoma cells with 11q13 amplification is associated with both overexpression and post-translational modification.
    van Damme H; Brok H; Schuuring-Scholtes E; Schuuring E
    J Biol Chem; 1997 Mar; 272(11):7374-80. PubMed ID: 9054437
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells.
    Lee WJ; Chen WK; Wang CJ; Lin WL; Tseng TH
    Toxicol Appl Pharmacol; 2008 Jan; 226(2):178-91. PubMed ID: 17961621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of Arp2/3 complex-mediated actin polymerization by cortactin.
    Uruno T; Liu J; Zhang P; Fan Yx ; Egile C; Li R; Mueller SC; Zhan X
    Nat Cell Biol; 2001 Mar; 3(3):259-66. PubMed ID: 11231575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Estrogens, cathepsin D and metastasis in cancers of the breast and ovary: invasion or proliferation?].
    Rochefort H
    C R Seances Soc Biol Fil; 1998; 192(2):241-51. PubMed ID: 9841098
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Consequences of altered TGF-beta expression and responsiveness in breast cancer: evidence for autocrine and paracrine effects.
    Tobin SW; Douville K; Benbow U; Brinckerhoff CE; Memoli VA; Arrick BA
    Oncogene; 2002 Jan; 21(1):108-18. PubMed ID: 11791181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cortactin promotes cell motility by enhancing lamellipodial persistence.
    Bryce NS; Clark ES; Leysath JL; Currie JD; Webb DJ; Weaver AM
    Curr Biol; 2005 Jul; 15(14):1276-85. PubMed ID: 16051170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RhoC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer phenotype.
    van Golen KL; Wu ZF; Qiao XT; Bao LW; Merajver SD
    Cancer Res; 2000 Oct; 60(20):5832-8. PubMed ID: 11059780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of raf kinase inhibitor protein expression on metastasis and progression of human breast cancer.
    Li HZ; Gao Y; Zhao XL; Liu YX; Sun BC; Yang J; Yao Z
    Mol Cancer Res; 2009 Jun; 7(6):832-40. PubMed ID: 19531568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dissecting the functional domain requirements of cortactin in invadopodia formation.
    Webb BA; Jia L; Eves R; Mak AS
    Eur J Cell Biol; 2007 Apr; 86(4):189-206. PubMed ID: 17343955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [HS1 and EMS1].
    He H
    Gan To Kagaku Ryoho; 1997 Sep; 24(11):1448-53. PubMed ID: 9309140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The product of the EMS1 gene, amplified and overexpressed in human carcinomas, is homologous to a v-src substrate and is located in cell-substratum contact sites.
    Schuuring E; Verhoeven E; Litvinov S; Michalides RJ
    Mol Cell Biol; 1993 May; 13(5):2891-98. PubMed ID: 8474448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glycolysis and growth rate in normal and in hexokinase-transfected NIH-3T3 cells.
    Fanciulli M; Paggi MG; Bruno T; Del Carlo C; Bonetto F; Gentile FP; Floridi A
    Oncol Res; 1994; 6(9):405-9. PubMed ID: 7703526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Signaling pathways and structural domains required for phosphorylation of EMS1/cortactin.
    Campbell DH; Sutherland RL; Daly RJ
    Cancer Res; 1999 Oct; 59(20):5376-85. PubMed ID: 10537323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression and tyrosine phosphorylation of EMS1 in human breast cancer cell lines.
    Campbell DH; deFazio A; Sutherland RL; Daly RJ
    Int J Cancer; 1996 Nov; 68(4):485-92. PubMed ID: 8945620
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclin D1, EMS1 and 11q13 amplification in breast cancer.
    Ormandy CJ; Musgrove EA; Hui R; Daly RJ; Sutherland RL
    Breast Cancer Res Treat; 2003 Apr; 78(3):323-35. PubMed ID: 12755491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cortactin underpins CD44-promoted invasion and adhesion of breast cancer cells to bone marrow endothelial cells.
    Hill A; McFarlane S; Mulligan K; Gillespie H; Draffin JE; Trimble A; Ouhtit A; Johnston PG; Harkin DP; McCormick D; Waugh DJ
    Oncogene; 2006 Oct; 25(45):6079-91. PubMed ID: 16652145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.